Skip to main content

Table 2 HCMV seroprevalence and HCV and/or HBV infection in the Department of Hepatology.

From: Increased HCMV seroprevalence in patients with hepatocellular carcinoma

Department Hepatology HCV and/or HBV Patients HCMV seropositivity (%) Age (years, mean)
Division 1 Positive 30 80.0 49.7
  Negative 34 64.7 41.3
Division 2 Positive 49 81.6 58.5
  Negative 99 58.6 57.4
Division 3 Positive 52 78.8 54.6
  Negative 133 57.9 55.3
Total Positive 164 76.2 55.0
  Negative 446 56.5 53.3